vs

Side-by-side financial comparison of ALERUS FINANCIAL CORP (ALRS) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

ALERUS FINANCIAL CORP is the larger business by last-quarter revenue ($45.2M vs $37.2M, roughly 1.2× Organogenesis Holdings Inc.). On growth, ALERUS FINANCIAL CORP posted the faster year-over-year revenue change (18.0% vs -57.1%). Over the past eight quarters, ALERUS FINANCIAL CORP's revenue compounded faster (-2.5% CAGR vs -46.5%).

Alerus Financial Corporation, marketed as simply Alerus, is a chain of financial institutions headquartered in Grand Forks, North Dakota, with locations in North Dakota, Minnesota, Wisconsin, and Arizona. Alerus offers banking, mortgage, wealth management, and retirement services.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

ALRS vs ORGO — Head-to-Head

Bigger by revenue
ALRS
ALRS
1.2× larger
ALRS
$45.2M
$37.2M
ORGO
Growing faster (revenue YoY)
ALRS
ALRS
+75.1% gap
ALRS
18.0%
-57.1%
ORGO
Faster 2-yr revenue CAGR
ALRS
ALRS
Annualised
ALRS
-2.5%
-46.5%
ORGO

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ALRS
ALRS
ORGO
ORGO
Revenue
$45.2M
$37.2M
Net Profit
$-33.1M
Gross Margin
30.8%
Operating Margin
-96.0%
-185.1%
Net Margin
-73.2%
Revenue YoY
18.0%
-57.1%
Net Profit YoY
-49232.8%
EPS (diluted)
$-1.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALRS
ALRS
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$45.2M
$225.6M
Q3 25
$72.6M
$150.9M
Q2 25
$74.8M
$101.0M
Q1 25
$68.8M
$86.7M
Q4 24
$72.2M
$126.7M
Q3 24
$50.9M
$115.2M
Q2 24
$51.4M
$130.2M
Net Profit
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
$-33.1M
$43.7M
Q3 25
$16.9M
$21.6M
Q2 25
$20.3M
$-9.4M
Q1 25
$13.3M
$-18.8M
Q4 24
$-67.0K
$7.7M
Q3 24
$5.2M
$12.3M
Q2 24
$6.2M
$-17.0M
Gross Margin
ALRS
ALRS
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
ALRS
ALRS
ORGO
ORGO
Q1 26
-185.1%
Q4 25
-96.0%
28.1%
Q3 25
30.4%
13.7%
Q2 25
35.2%
-12.5%
Q1 25
25.5%
-30.9%
Q4 24
-0.8%
8.1%
Q3 24
13.4%
5.4%
Q2 24
15.8%
-10.7%
Net Margin
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
-73.2%
19.4%
Q3 25
23.3%
14.3%
Q2 25
27.1%
-9.3%
Q1 25
19.4%
-21.7%
Q4 24
-0.2%
6.1%
Q3 24
10.2%
10.7%
Q2 24
12.1%
-13.1%
EPS (diluted)
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
$-1.27
$0.31
Q3 25
$0.65
$0.11
Q2 25
$0.78
$-0.10
Q1 25
$0.52
$-0.17
Q4 24
$-0.06
$0.05
Q3 24
$0.26
$0.09
Q2 24
$0.31
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALRS
ALRS
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$67.2M
$91.4M
Total DebtLower is stronger
$59.2M
Stockholders' EquityBook value
$564.9M
Total Assets
$5.2B
$520.0M
Debt / EquityLower = less leverage
0.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALRS
ALRS
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$67.2M
$93.7M
Q3 25
$92.0M
$63.7M
Q2 25
$80.9M
$73.1M
Q1 25
$83.0M
$110.0M
Q4 24
$61.2M
$135.6M
Q3 24
$66.0M
$94.3M
Q2 24
$438.1M
$89.9M
Total Debt
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
$59.2M
Q3 25
$59.2M
Q2 25
$59.1M
Q1 25
$59.1M
Q4 24
$59.1M
Q3 24
$59.0M
$62.3M
Q2 24
$59.0M
$63.8M
Stockholders' Equity
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
$564.9M
$300.1M
Q3 25
$550.7M
$255.1M
Q2 25
$533.2M
$233.2M
Q1 25
$514.2M
$242.9M
Q4 24
$495.4M
$262.9M
Q3 24
$386.5M
$278.5M
Q2 24
$373.2M
$263.5M
Total Assets
ALRS
ALRS
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$5.2B
$598.7M
Q3 25
$5.3B
$509.8M
Q2 25
$5.3B
$461.1M
Q1 25
$5.3B
$467.4M
Q4 24
$5.3B
$497.9M
Q3 24
$4.4B
$446.3M
Q2 24
$4.4B
$443.2M
Debt / Equity
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
0.10×
Q3 25
0.11×
Q2 25
0.11×
Q1 25
0.11×
Q4 24
0.12×
Q3 24
0.15×
0.22×
Q2 24
0.16×
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALRS
ALRS
ORGO
ORGO
Operating Cash FlowLast quarter
$67.5M
Free Cash FlowOCF − Capex
$58.8M
FCF MarginFCF / Revenue
130.2%
Capex IntensityCapex / Revenue
19.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$102.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
$67.5M
$39.4M
Q3 25
$32.8M
$3.1M
Q2 25
$10.7M
$-32.9M
Q1 25
$7.7M
$-19.9M
Q4 24
$21.7M
$10.9M
Q3 24
$20.2M
$8.7M
Q2 24
$-12.5M
$4.7M
Free Cash Flow
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
$58.8M
$34.8M
Q3 25
$30.3M
$844.0K
Q2 25
$7.6M
$-36.5M
Q1 25
$5.7M
$-23.6M
Q4 24
$9.4M
$7.6M
Q3 24
$17.4M
$6.1M
Q2 24
$-16.1M
$2.9M
FCF Margin
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
130.2%
15.4%
Q3 25
41.8%
0.6%
Q2 25
10.1%
-36.1%
Q1 25
8.2%
-27.2%
Q4 24
13.0%
6.0%
Q3 24
34.2%
5.3%
Q2 24
-31.4%
2.2%
Capex Intensity
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
19.3%
2.1%
Q3 25
3.4%
1.5%
Q2 25
4.2%
3.6%
Q1 25
3.0%
4.2%
Q4 24
17.1%
2.7%
Q3 24
5.4%
2.2%
Q2 24
7.2%
1.4%
Cash Conversion
ALRS
ALRS
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
1.94×
0.14×
Q2 25
0.53×
Q1 25
0.58×
Q4 24
1.43×
Q3 24
3.88×
0.71×
Q2 24
-2.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALRS
ALRS

Other$17.3M38%
Retirement And Benefit Services$17.3M38%
Wealth Management$7.4M16%
Mortgage Banking$3.2M7%

ORGO
ORGO

Segment breakdown not available.

Related Comparisons